Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Obeticholic-acid | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Obeticholic-acid | hsa00190 | Oxidative phosphorylation | 2.21E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Obeticholic-acid | hsa00220 | Arginine biosynthesis | 1.94E-03 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Obeticholic-acid | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.32E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Obeticholic-acid | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Obeticholic-acid | hsa00330 | Arginine and proline metabolism | 4.86E-02 | 1 | P17707 | AMD1 | More | | Obeticholic-acid | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Obeticholic-acid | hsa00561 | Glycerolipid metabolism | 1.37E-03 | 4 | O14494, P51648, P06280, P23743 | PLPP1, ALDH3A2, GLA, DGKA | More | | Obeticholic-acid | hsa00562 | Inositol phosphate metabolism | 7.30E-04 | 4 | P27987, Q96PE3, P19174, P42338 | ITPKB, INPP4A, PLCG1, PIK3CB | More | | Obeticholic-acid | hsa00600 | Sphingolipid metabolism | 3.96E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | | Obeticholic-acid | hsa00620 | Pyruvate metabolism | 2.51E-02 | 2 | P40925, P51648 | MDH1, ALDH3A2 | More | | Obeticholic-acid | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.78E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Obeticholic-acid | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Obeticholic-acid | hsa00910 | Nitrogen metabolism | 4.32E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Obeticholic-acid | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.08E-04 | 4 | Q16772, P78417, P09211, P11712 | GSTA3, GSTO1, GSTP1, CYP2C9 | More | | Obeticholic-acid | hsa00982 | Drug metabolism - cytochrome P450 | 7.77E-04 | 4 | P11712, Q16772, P09211, P78417 | CYP2C9, GSTA3, GSTP1, GSTO1 | More | | Obeticholic-acid | hsa00983 | Drug metabolism - other enzymes | 1.72E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Obeticholic-acid | hsa01100 | Metabolic pathways | 1.44E-03 | 23 | P35790, Q16772, P09211, Q9UJ14, P30041, P15104, P51648, P42338, Q96PE3, P19174, P27987, Q13370, P40925, P40926, Q7KZN9, P15121, P23743, Q9UHK6, P43034, Q86VZ5, P09917, Q53FZ2, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, GLUL, ALDH3A2, PIK3CB, INPP4A, PLCG1, ITPKB, PDE3B, MDH1, MDH2, COX15, AKR1B1, DGKA, AMACR, PAFAH1B1, SGMS1, ALOX5, ACSM3, VKORC1 | More | | Obeticholic-acid | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.43E-02 | 1 | P50213 | IDH3A | More | | Obeticholic-acid | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Obeticholic-acid | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 7.30E-04 | 4 | Q92529, P19174, P42338, Q9NRA1 | SHC3, PLCG1, PIK3CB, PDGFC | More | | Obeticholic-acid | hsa01524 | Platinum drug resistance | 3.80E-03 | 4 | O15392, Q16772, P09211, P11388 | BIRC5, GSTA3, GSTP1, TOP2A | More | | Obeticholic-acid | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Obeticholic-acid | hsa03013 | RNA transport | 2.35E-05 | 10 | O14980, P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, Q14240, P23588, Q9Y6A5 | XPO1, NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF4A2, EIF4B, TACC3 | More | | Obeticholic-acid | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Obeticholic-acid | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Obeticholic-acid | hsa03040 | Spliceosome | 1.27E-02 | 6 | O43143, P08579, Q13595, Q07955, P84103, P11142 | DHX15, SNRPB2, TRA2A, SFRS1, SFRS3, HSPA8 | More | | Obeticholic-acid | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Obeticholic-acid | hsa04012 | ErbB signaling pathway | 9.49E-03 | 3 | Q92529, P19174, P42338 | SHC3, PLCG1, PIK3CB | More | | Obeticholic-acid | hsa04014 | Ras signaling pathway | 6.70E-05 | 10 | P42338, Q92529, P20827, Q9NRA1, P49767, Q14644, P0DP23, P63218, P50151, P19174 | PIK3CB, SHC3, EFNA1, PDGFC, VEGFC, RASA3, CALM1, GNG5, GNG10, PLCG1 | More | | Obeticholic-acid | hsa04015 | Rap1 signaling pathway | 3.91E-02 | 4 | Q9NRA1, P49767, P42338, P19174 | PDGFC, VEGFC, PIK3CB, PLCG1 | More | | Obeticholic-acid | hsa04020 | Calcium signaling pathway | 2.74E-05 | 11 | P27987, Q16566, P30679, O15399, P19174, P0DP24, P0DP23, P51828, P23634, Q9NRA1, P49767 | ITPKB, CAMK4, GNA15, GRIN2D, PLCG1, CALM2, CALM1, ADCY7, ATP2B4, PDGFC, VEGFC | More | | Obeticholic-acid | hsa04024 | cAMP signaling pathway | 3.79E-02 | 3 | P51828, P0DP24, P23634 | ADCY7, CALM2, ATP2B4 | More | | Obeticholic-acid | hsa04062 | Chemokine signaling pathway | 2.13E-04 | 11 | P25024, P25025, P07948, P42338, P19174, Q92529, P63218, P50151, P49407, Q08881, P49841 | CXCR1, CXCR2, LYN, PIK3CB, PLCG1, SHC3, GNG5, GNG10, ARRB1, ITK, GSK3B | More | | Obeticholic-acid | hsa04064 | NF-kappa B signaling pathway | 2.35E-02 | 4 | P01584, P63279, Q8NHW4, Q9NQC7 | IL1B, UBE2I, CCL4L2, CYLD | More | | Obeticholic-acid | hsa04070 | Phosphatidylinositol signaling system | 3.19E-04 | 5 | P19174, P42338, P23743, Q96PE3, P27987 | PLCG1, PIK3CB, DGKA, INPP4A, ITPKB | More | | Obeticholic-acid | hsa04071 | Sphingolipid signaling pathway | 2.14E-02 | 3 | Q13510, Q13362, Q9UQC2 | ASAH1, PPP2R5C, GAB2 | More | | Obeticholic-acid | hsa04072 | Phospholipase D signaling pathway | 3.21E-05 | 10 | P42338, Q92529, P43657, P25024, P25025, P19174, Q14344, P23743, Q9NRA1, Q9GZP0 | PIK3CB, SHC3, P2RY5, CXCR1, CXCR2, PLCG1, GNA13, DGKA, PDGFC, PDGFD | More | | Obeticholic-acid | hsa04114 | Oocyte meiosis | 8.69E-03 | 4 | P0DP24, P51828, P27348, Q13362 | CALM2, ADCY7, YWHAQ, PPP2R5C | More | | Obeticholic-acid | hsa04120 | Ubiquitin mediated proteolysis | 2.57E-02 | 4 | Q14145, Q13042, Q93034, Q15751 | KEAP1, CDC16, CUL5, HERC1 | More | | Obeticholic-acid | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Obeticholic-acid | hsa04141 | Protein processing in endoplasmic reticulum | 2.78E-02 | 3 | P07384, O95487, O95816 | CAPN1, SEC24B, BAG2 | More | | Obeticholic-acid | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Obeticholic-acid | hsa04144 | Endocytosis | 1.67E-02 | 8 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, SNX12 | More | | Obeticholic-acid | hsa04145 | Phagosome | 3.94E-02 | 6 | P60709, Q15075, Q15080, P14598, Q13509, Q13488 | ACTB, EEA1, NCF4, NCF1, TUBB3, TCIRG1 | More | | Obeticholic-acid | hsa04151 | PI3K-Akt signaling pathway | 2.55E-03 | 8 | P42338, Q9NRA1, P49767, P08238, P63218, P50151, O15335, P14784 | PIK3CB, PDGFC, VEGFC, HSP90AB1, GNG5, GNG10, CHAD, IL2RB | More | | Obeticholic-acid | hsa04213 | Longevity regulating pathway - multiple species | 2.82E-02 | 3 | Q08828, P51828, P0DMV8 | ADCY1, ADCY7, HSPA1A | More | | Obeticholic-acid | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.06E-02 | 4 | P51828, Q13362, P0DP24, P23634 | ADCY7, PPP2R5C, CALM2, ATP2B4 | More | | Obeticholic-acid | hsa04270 | Vascular smooth muscle contraction | 6.96E-03 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Obeticholic-acid | hsa04360 | Axon guidance | 1.50E-02 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | | Obeticholic-acid | hsa04370 | VEGF signaling pathway | 1.56E-02 | 2 | P19174, P42338 | PLCG1, PIK3CB | More | | Obeticholic-acid | hsa04371 | Apelin signaling pathway | 1.56E-03 | 7 | P63218, P50151, Q13370, Q14344, Q13485, Q16566, P0DP23 | GNG5, GNG10, PDE3B, GNA13, SMAD4, CAMK4, CALM1 | More | | Obeticholic-acid | hsa04380 | Osteoclast differentiation | 3.37E-03 | 8 | P09603, P06239, P42338, P14778, O75015, P01375, Q8N149, P78324 | CSF1, LCK, PIK3CB, IL1R1, FCGR3B, TNF, LILRA2, SIRPA | More | | Obeticholic-acid | hsa04510 | Focal adhesion | 1.55E-02 | 5 | P42338, O15335, Q9NRA1, P49767, Q92529 | PIK3CB, CHAD, PDGFC, VEGFC, SHC3 | More | | Obeticholic-acid | hsa04530 | Tight junction | 2.08E-02 | 3 | P63261, Q9Y478, Q92974 | ACTG1, PRKAB1, ARHGEF2 | More | | Obeticholic-acid | hsa04610 | Complement and coagulation cascades | 4.48E-02 | 3 | P01042, P09871, P11215 | KNG1, C1S, ITGAM | More | | Obeticholic-acid | hsa04611 | Platelet activation | 4.11E-02 | 3 | P42338, Q14344, P07948 | PIK3CB, GNA13, LYN | More | | Obeticholic-acid | hsa04612 | Antigen processing and presentation | 4.12E-02 | 3 | O43908, P30511, P01375 | KLRC4, HLA-F, TNF | More | | Obeticholic-acid | hsa04621 | NOD-like receptor signaling pathway | 3.24E-02 | 4 | P52630, P10599, P01375, P12838 | STAT2, TXN, TNF, DEFA4 | More | | Obeticholic-acid | hsa04623 | Cytosolic DNA-sensing pathway | 1.65E-02 | 2 | P01584, Q8NHW4 | IL1B, CCL4L2 | More | | Obeticholic-acid | hsa04625 | C-type lectin receptor signaling pathway | 2.38E-03 | 6 | Q9ULY5, P52630, P20749, P01375, Q13191, P42338 | CLEC4E, STAT2, BCL3, TNF, CBLB, PIK3CB | More | | Obeticholic-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 1.79E-02 | 7 | P01375, P06239, O60880, P20963, P42338, P26718, O75015 | TNF, LCK, SH2D1A, CD247, PIK3CB, KLRK1, FCGR3B | More | | Obeticholic-acid | hsa04657 | IL-17 signaling pathway | 3.06E-02 | 3 | P49841, P80188, P01375 | GSK3B, LCN2, TNF | More | | Obeticholic-acid | hsa04658 | Th1 and Th2 cell differentiation | 1.01E-02 | 4 | P07766, P19174, P14784, Q13761 | CD3E, PLCG1, IL2RB, RUNX3 | More | | Obeticholic-acid | hsa04659 | Th17 cell differentiation | 2.16E-02 | 4 | P19174, P14784, P08238, P07766 | PLCG1, IL2RB, HSP90AB1, CD3E | More | | Obeticholic-acid | hsa04660 | T cell receptor signaling pathway | 6.23E-03 | 8 | P01375, P42338, Q08881, P07766, P20963, Q13191, P06239, P49841 | TNF, PIK3CB, ITK, CD3E, CD247, CBLB, LCK, GSK3B | More | | Obeticholic-acid | hsa04662 | B cell receptor signaling pathway | 1.32E-03 | 5 | P49841, P42338, P60033, P07948, Q8N149 | GSK3B, PIK3CB, CD81, LYN, LILRA2 | More | | Obeticholic-acid | hsa04664 | Fc epsilon RI signaling pathway | 6.90E-05 | 5 | P01375, P42338, P07948, P19174, P09917 | TNF, PIK3CB, LYN, PLCG1, ALOX5 | More | | Obeticholic-acid | hsa04666 | Fc gamma R-mediated phagocytosis | 1.73E-02 | 3 | P07948, P42338, P19174 | LYN, PIK3CB, PLCG1 | More | | Obeticholic-acid | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Obeticholic-acid | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | | Obeticholic-acid | hsa04720 | Long-term potentiation | 1.79E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Obeticholic-acid | hsa04722 | Neurotrophin signaling pathway | 4.87E-02 | 3 | P42338, P19174, Q92529 | PIK3CB, PLCG1, SHC3 | More | | Obeticholic-acid | hsa04724 | Glutamatergic synapse | 2.04E-03 | 5 | O15399, P63218, P50151, P15104, Q9NSB8 | GRIN2D, GNG5, GNG10, GLUL, HOMER2 | More | | Obeticholic-acid | hsa04725 | Cholinergic synapse | 1.73E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Obeticholic-acid | hsa04726 | Serotonergic synapse | 3.41E-02 | 3 | P63218, P50151, P09917 | GNG5, GNG10, ALOX5 | More | | Obeticholic-acid | hsa04727 | GABAergic synapse | 6.57E-03 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Obeticholic-acid | hsa04730 | Long-term depression | 1.56E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Obeticholic-acid | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.01E-02 | 4 | P01584, Q08828, P51828, P0DP23 | IL1B, ADCY1, ADCY7, CALM1 | More | | Obeticholic-acid | hsa04910 | Insulin signaling pathway | 4.11E-02 | 3 | Q92529, Q13370, P42338 | SHC3, PDE3B, PIK3CB | More | | Obeticholic-acid | hsa04914 | Progesterone-mediated oocyte maturation | 2.22E-02 | 3 | P42338, Q13370, P08238 | PIK3CB, PDE3B, HSP90AB1 | More | | Obeticholic-acid | hsa04915 | Estrogen signaling pathway | 3.80E-04 | 9 | Q08828, P51828, P42338, Q92529, P08238, P0DMV8, P11142, P0DP23, Q15788 | ADCY1, ADCY7, PIK3CB, SHC3, HSP90AB1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Obeticholic-acid | hsa04920 | Adipocytokine signaling pathway | 2.62E-03 | 3 | Q06124, Q9Y478, Q96RR4 | PTPN11, PRKAB1, CAMKK2 | More | | Obeticholic-acid | hsa04923 | Regulation of lipolysis in adipocytes | 3.64E-02 | 2 | Q13370, P42338 | PDE3B, PIK3CB | More | | Obeticholic-acid | hsa04925 | Aldosterone synthesis and secretion | 1.40E-03 | 5 | P51828, P0DP24, P0DP23, Q16566, P23634 | ADCY7, CALM2, CALM1, CAMK4, ATP2B4 | More | | Obeticholic-acid | hsa04926 | Relaxin signaling pathway | 1.31E-03 | 5 | P42338, P63218, P50151, P49767, Q92529 | PIK3CB, GNG5, GNG10, VEGFC, SHC3 | More | | Obeticholic-acid | hsa04932 | Non-alcoholic fatty liver disease | 1.39E-02 | 6 | O43521, O75460, P01584, P13073, P12074, O95298 | BCL2L11, ERN1, IL1B, COX4I1, COX6A1, NDUFC2 | More | | Obeticholic-acid | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 4.11E-02 | 3 | P42338, P49767, P19174 | PIK3CB, VEGFC, PLCG1 | More | | Obeticholic-acid | hsa04935 | Growth hormone synthesis, secretion and action | 2.78E-02 | 3 | P19174, P42338, Q92529 | PLCG1, PIK3CB, SHC3 | More | | Obeticholic-acid | hsa04940 | Type I diabetes mellitus | 1.58E-02 | 2 | P30511, P01375 | HLA-F, TNF | More | | Obeticholic-acid | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 2.09E-02 | 2 | P23634, P62491 | ATP2B4, RAB11A | More | | Obeticholic-acid | hsa04970 | Salivary secretion | 6.83E-04 | 5 | Q08828, P51828, P23634, P0DP24, P0DP23 | ADCY1, ADCY7, ATP2B4, CALM2, CALM1 | More | | Obeticholic-acid | hsa04972 | Pancreatic secretion | 4.94E-03 | 3 | P23634, P51828, P62491 | ATP2B4, ADCY7, RAB11A | More | | Obeticholic-acid | hsa04973 | Carbohydrate digestion and absorption | 1.57E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Obeticholic-acid | hsa04976 | Bile secretion | 4.78E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Obeticholic-acid | hsa05010 | Alzheimer disease | 3.75E-02 | 8 | P01375, Q9NZJ5, Q13564, P49841, Q92837, P09603, P42338, P21796 | TNF, EIF2AK3, APPBP1, GSK3B, FRAT1, CSF1, PIK3CB, VDAC1 | More | | Obeticholic-acid | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | | Obeticholic-acid | hsa05032 | Morphine addiction | 2.22E-02 | 3 | P63218, P50151, Q13370 | GNG5, GNG10, PDE3B | More | | Obeticholic-acid | hsa05034 | Alcoholism | 1.05E-02 | 6 | O15399, Q16566, P0DP23, P63218, O60814, P68431 | GRIN2D, CAMK4, CALM1, GNG5, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Obeticholic-acid | hsa05100 | Bacterial invasion of epithelial cells | 3.64E-02 | 2 | P42338, Q92529 | PIK3CB, SHC3 | More | | Obeticholic-acid | hsa05110 | Vibrio cholerae infection | 4.50E-03 | 4 | Q13488, P17252, P19174, P60709 | TCIRG1, PRKCA, PLCG1, ACTB | More | | Obeticholic-acid | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | | Obeticholic-acid | hsa05133 | Pertussis | 1.70E-03 | 4 | P11215, P0DP23, P23528, P09871 | ITGAM, CALM1, CFL1, C1S | More | | Obeticholic-acid | hsa05134 | Legionellosis | 2.82E-02 | 3 | P01584, Q9NR31, P0DMV8 | IL1B, SAR1A, HSPA1A | More | | Obeticholic-acid | hsa05135 | Yersinia infection | 4.00E-02 | 5 | P13612, P06239, P01375, P42338, P49841 | ITGA4, LCK, TNF, PIK3CB, GSK3B | More | | Obeticholic-acid | hsa05140 | Leishmaniasis | 4.75E-02 | 5 | P14598, P42224, P25963, P29350, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, NCF4 | More | | Obeticholic-acid | hsa05160 | Hepatitis C | 9.27E-03 | 4 | P52630, P60033, P49841, P01375 | STAT2, CD81, GSK3B, TNF | More | | Obeticholic-acid | hsa05162 | Measles | 5.79E-03 | 8 | P23458, P14784, P07766, P42338, P0DMV8, P11142, P01584, Q9NP90 | JAK1, IL2RB, CD3E, PIK3CB, HSPA1A, HSPA8, IL1B, RAB9B | More | | Obeticholic-acid | hsa05163 | Human cytomegalovirus infection | 1.23E-06 | 18 | P42338, P01375, P30511, P63218, P50151, P0DP23, Q14344, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, O00463, P30101 | PIK3CB, TNF, HLA-F, GNG5, GNG10, CALM1, GNA13, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, TRAF5, PDIA3 | More | | Obeticholic-acid | hsa05165 | Human papillomavirus infection | 1.76E-02 | 5 | P49841, P24821, P01375, P52630, P30511 | GSK3B, TNC, TNF, STAT2, HLA-F | More | | Obeticholic-acid | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.14E-02 | 5 | P42338, P63218, P50151, P19174, P07948 | PIK3CB, GNG5, GNG10, PLCG1, LYN | More | | Obeticholic-acid | hsa05169 | Epstein-Barr virus infection | 8.75E-04 | 10 | Q13547, O00463, P42338, P07948, P30511, P30101, Q13761, P01375, P07766, P20963 | HDAC1, TRAF5, PIK3CB, LYN, HLA-F, PDIA3, RUNX3, TNF, CD3E, CD247 | More | | Obeticholic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 6.31E-04 | 10 | P42338, P30511, P63218, P50151, P01375, O00463, P30101, P19174, P07766, P20963 | PIK3CB, HLA-F, GNG5, GNG10, TNF, TRAF5, PDIA3, PLCG1, CD3E, CD247 | More | | Obeticholic-acid | hsa05200 | Pathways in cancer | 3.05E-02 | 8 | P42338, P08238, P19174, P49767, P63218, P50151, Q14344, P14784 | PIK3CB, HSP90AB1, PLCG1, VEGFC, GNG5, GNG10, GNA13, IL2RB | More | | Obeticholic-acid | hsa05203 | Viral carcinogenesis | 4.62E-02 | 3 | Q12933, P42229, Q15283 | TRAF2, STAT5A, RASA2 | More | | Obeticholic-acid | hsa05204 | Chemical carcinogenesis | 7.77E-04 | 4 | Q16772, P09211, P78417, P11712 | GSTA3, GSTP1, GSTO1, CYP2C9 | More | | Obeticholic-acid | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Obeticholic-acid | hsa05214 | Glioma | 9.49E-03 | 3 | Q92529, P42338, P19174 | SHC3, PIK3CB, PLCG1 | More | | Obeticholic-acid | hsa05215 | Prostate cancer | 4.87E-02 | 3 | Q9NRA1, P08238, P42338 | PDGFC, HSP90AB1, PIK3CB | More | | Obeticholic-acid | hsa05218 | Melanoma | 3.64E-02 | 2 | Q9NRA1, P42338 | PDGFC, PIK3CB | More | | Obeticholic-acid | hsa05223 | Non-small cell lung cancer | 3.99E-02 | 4 | P17252, O43524, P19174, O75293 | PRKCA, FOXO3, PLCG1, GADD45B | More | | Obeticholic-acid | hsa05231 | Choline metabolism in cancer | 3.04E-04 | 6 | P42338, Q9NRA1, P19174, P23743, O14494, P17252 | PIK3CB, PDGFC, PLCG1, DGKA, PLPP1, PRKCA | More | | Obeticholic-acid | hsa05310 | Asthma | 9.71E-03 | 2 | P12724, P01375 | RNASE3, TNF | More | | Obeticholic-acid | hsa05330 | Allograft rejection | 2.30E-02 | 2 | P30511, P01375 | HLA-F, TNF | More | | Obeticholic-acid | hsa05332 | Graft-versus-host disease | 3.14E-02 | 2 | P30511, P01375 | HLA-F, TNF | More | | Obeticholic-acid | hsa05415 | Diabetic cardiomyopathy | 3.94E-02 | 6 | P17252, P14598, Q15080, Q16718, O14521, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH | More | | Obeticholic-acid | hsa05418 | Fluid shear stress and atherosclerosis | 4.52E-03 | 6 | P42338, Q14145, P10599, P01375, P14778, P27930 | PIK3CB, KEAP1, TXN, TNF, IL1R1, IL1R2 | More | | |